Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

C4 Therapeutics (CCCC) Return on Assets (2020 - 2026)

C4 Therapeutics has reported Return on Assets over the past 7 years, most recently at 0.0% for Q1 2026.

  • For Q1 2026, Return on Assets changed 0.0% year-over-year to 0.0%; the TTM value through Mar 2026 reached 0.0%, changed 0.0%, while the annual FY2025 figure was 0.0%, 0.0% changed from the prior year.
  • Return on Assets for Q1 2026 was 0.0% at C4 Therapeutics, up from 0.0% in the prior quarter.
  • Over five years, Return on Assets peaked at 0.0% in Q1 2022 and troughed at 0.0% in Q3 2025.
  • A 5-year average of 0.0% and a median of 0.0% in 2025 define the central range for Return on Assets.
  • On a YoY basis, Return on Assets climbed as much as 0bps in 2022 and fell as far as 0bps in 2022.
  • Year by year, Return on Assets stood at 0.0% in 2022, then plummeted by -31bps to 0.0% in 2023, then increased by 22bps to 0.0% in 2024, then fell by -16bps to 0.0% in 2025, then grew by 10bps to 0.0% in 2026.
  • Business Quant data shows Return on Assets for CCCC at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.